Banner University Medical Center Phoenix Heart Institute, Phoenix.
University of Arizona College of Medicine, Phoenix, Arizona.
Curr Opin Cardiol. 2019 Jan;34(1):1-5. doi: 10.1097/HCO.0000000000000578.
With the growing popularity of the cryoballoon tool for catheter ablation of atrial fibrillation, there has been discussion of whether cryothermal energy is just as or more effective than traditional radiofrequency. This review will compare both thermal energies for the treatment of atrial fibrillation.
Although the FIRE and ICE trial established that cryoballoon technology is noninferior to radiofrequency ablation for the treatment of atrial fibrillation, both thermal technologies have undergone advancement. This review intends to explore recent changes in technology and catheter ablation technique to improve outcomes for patients with atrial fibrillation.
Catheter ablation is standard treatment for patients with atrial fibrillation, which primarily focuses on electrical isolation of the pulmonary veins. Radiofrequency is the most common approach at present times; however, over time, new technology has developed. Most successful among these is the cryoballoon tool. Although the FIRE and ICE trial indicated radiofrequency and cryothermal energy to be approximately equal in efficacy and safety, there are advantages and disadvantages to both. This review seeks to address the value of each tool, as well as further development needed to better address atrial fibrillation while improving procedural safety.
随着冷冻球囊工具在心房颤动导管消融中的应用越来越普及,人们开始讨论冷冻能与传统射频能的疗效孰优孰劣。本文将比较两种热能在心房颤动治疗中的应用。
尽管 FIRE 和 ICE 试验证实冷冻球囊技术在治疗心房颤动方面不劣于射频消融,但这两种热能都有了新的进展。本文旨在探讨技术和导管消融技术的最新变化,以改善心房颤动患者的治疗效果。
导管消融是心房颤动患者的标准治疗方法,主要侧重于肺静脉的电隔离。目前,射频是最常用的方法;然而,随着时间的推移,新技术已经发展起来。其中最成功的是冷冻球囊工具。尽管 FIRE 和 ICE 试验表明射频和冷冻能在疗效和安全性方面大致相当,但两者都有各自的优缺点。本文旨在探讨每种工具的价值,以及进一步发展以更好地解决心房颤动问题并提高手术安全性的必要性。